TCTR20221029004招募中4 期
Helicobacter Pylori Eradication Therapy Influencing Clinical Outcomes in Parkinson disease: A Randomized Controlled Trial
Ramathibodi Hospital, Mahidol University0 个研究点目标入组 60 人开始时间: 2022年10月29日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •Diagnosis of Idiopathic Parkinson disease (PD) by a neurologist
- •Written informed and consent given either by the patient or next of kin
- •Stable Parkinson disease with demonstrable medication efficacy (at least 90 days for L-DOPA therapy, 30 days for Dopamine agonist)
排除标准
- •Patients with other concomitant active neurological diseases
- •Patients with dysphagia
- •History of previous brain surgery for Parkinson's disease
- •History of recent antibiotics use, proton pump inhibitors (PPIs), histamine (H2) antagonist use for at least one month prior to stool antigen test
- •History of previous eradication therapy for Helicobacter pylori infection
- •History of a previous gastric or duodenal cancer
- •History of a previous gastric or major abdominal/pelvic surgery
- •Allergy or sensitivity of proton pump inhibitor, amoxicillin, metronidazole or clarithromycin
- •History of recent oral medication such as warfarin, and amiodarone (drug interaction with treatment protocol)
研究者
相似试验
尚未招募
不适用
Helicobacter pylori eradication therapy for the junior high school studentsHelicobacter pylori infectionJPRN-UMIN000017897Yurihonjyo and Nikaho city100
招募中
不适用
Tailored Helicobacter pylori eradication therapy based on prior exposure to Macrolide antibiotics: Prospective studyCertain infectious and parasitic diseasesKCT0007495Asan Medical Center60
已完成
不适用
Helicobacter pylori eradication from general practice: clinical benefits and health economicsDigestive system diseases: Peptic ulcer diseaseDigestive SystemPeptic ulcer diseaseISRCTN57634776HS R&D Regional Programme Register - Department of Health (UK)
招募中
不适用
Efficacy of tailored Helicobacter pylori eradication therapy based on susceptibility to antimicrobial agentsH. pylori-associated gastritisJPRN-UMIN000030270Shiga University of Medical Science Hospital310
尚未招募
不适用
Safety of Helicobacter pylori eradication therapy in patients with inflammatory bowel diseaseJPRN-UMIN000017105Osaka medical collage100